Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Depression and Anxiety
|
September 22, 2000
Subsyndromal symptomatic depression: a new concept
N Sadek, J Bona
The Journal of Biological Chemistry
|
June 10, 1982
Mucin biosynthesis. Characterization of UDP-galactose: alpha-N-acetylgalactosaminide beta 3 galactosyltransferase from human tracheal epithelium
P W Cheng, S J Bona
Endocrinology
|
March 1, 1995
Modulation of glucocorticoid-regulated transcription by purines: novel characteristics and implications for tissue specificity of steroid responses
S K Nordeen, M L Moyer, B J Bona
Endocrinology
|
April 1, 1994
The coupling of multiple signal transduction pathways with steroid response mechanisms
S K Nordeen, M L Moyer, B J Bona
Molecular Endocrinology (Baltimore, Md.)
|
June 1, 1993
Latent agonist activity of the steroid antagonist, RU486, is unmasked in cells treated with activators of protein kinase A
S K Nordeen, B J Bona, M L Moyer
Molecular Endocrinology (Baltimore, Md.)
|
April 1, 1993
The constitution of a progesterone response element
B A Lieberman, B J Bona, D P Edwards, et al.
Hormones & Cancer
|
July 10, 2013
Endocrine disrupting activities of the flavonoid nutraceuticals luteolin and quercetin
Steven K Nordeen, Betty J Bona, David N Jones, et al.
The Journal of Biological Chemistry
|
October 25, 1993
Modulation of cell signaling pathways can enhance or impair glucocorticoid-induced gene expression without altering the state of receptor phosphorylation
M L Moyer, K C Borror, B J Bona, et al.
Biomedicines
|
March 28, 2025
Endocrine-Disrupting Activities of Flavones on Steroid Receptors: Structural Requirements and Synthesis of Novel Flavone with Improved Estrogenic Activity
Steven K Nordeen, Vijay Kumar, Betty J Bona, et al.
Steroids
|
January 1, 1995
The two faces of a steroid antagonist: when an antagonist isn't
S K Nordeen, B J Bona, C A Beck, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Depression and Anxiety
|
September 22, 2000
Subsyndromal symptomatic depression: a new concept
N Sadek, J Bona
The Journal of Biological Chemistry
|
June 10, 1982
Mucin biosynthesis. Characterization of UDP-galactose: alpha-N-acetylgalactosaminide beta 3 galactosyltransferase from human tracheal epithelium
P W Cheng, S J Bona
Endocrinology
|
March 1, 1995
Modulation of glucocorticoid-regulated transcription by purines: novel characteristics and implications for tissue specificity of steroid responses
S K Nordeen, M L Moyer, B J Bona
Endocrinology
|
April 1, 1994
The coupling of multiple signal transduction pathways with steroid response mechanisms
S K Nordeen, M L Moyer, B J Bona
Molecular Endocrinology (Baltimore, Md.)
|
June 1, 1993
Latent agonist activity of the steroid antagonist, RU486, is unmasked in cells treated with activators of protein kinase A
S K Nordeen, B J Bona, M L Moyer
Molecular Endocrinology (Baltimore, Md.)
|
April 1, 1993
The constitution of a progesterone response element
B A Lieberman, B J Bona, D P Edwards, et al.
Hormones & Cancer
|
July 10, 2013
Endocrine disrupting activities of the flavonoid nutraceuticals luteolin and quercetin
Steven K Nordeen, Betty J Bona, David N Jones, et al.
The Journal of Biological Chemistry
|
October 25, 1993
Modulation of cell signaling pathways can enhance or impair glucocorticoid-induced gene expression without altering the state of receptor phosphorylation
M L Moyer, K C Borror, B J Bona, et al.
Biomedicines
|
March 28, 2025
Endocrine-Disrupting Activities of Flavones on Steroid Receptors: Structural Requirements and Synthesis of Novel Flavone with Improved Estrogenic Activity
Steven K Nordeen, Vijay Kumar, Betty J Bona, et al.
Steroids
|
January 1, 1995
The two faces of a steroid antagonist: when an antagonist isn't
S K Nordeen, B J Bona, C A Beck, et al.
Page
of 2